Belite Bio Statistics

Total Valuation

Belite Bio has a market cap or net worth of $1.85 billion. The enterprise value is $1.71 billion.

Market Cap	1.85B
Enterprise Value	1.71B

Important Dates

The next estimated earnings date is Monday, May 12, 2025, after market close.

Earnings Date	May 12, 2025
Ex-Dividend Date	n/a

Share Statistics

Belite Bio has 31.84 million shares outstanding. The number of shares has increased by 14.83% in one year.

Current Share Class	n/a
Shares Outstanding	31.84M
Shares Change (YoY)	+14.83%
Shares Change (QoQ)	+2.52%
Owned by Insiders (%)	1.43%
Owned by Institutions (%)	1.11%
Float	14.29M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	12.71
P/TBV Ratio	12.72
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 24.31, with a Debt / Equity ratio of 0.00.

Current Ratio	24.31
Quick Ratio	24.09
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1,999.80

Financial Efficiency

Return on equity (ROE) is -30.60% and return on invested capital (ROIC) is -21.04%.

Return on Equity (ROE)	-30.60%
Return on Assets (ROA)	-20.26%
Return on Invested Capital (ROIC)	-21.04%
Return on Capital Employed (ROCE)	-27.38%
Revenue Per Employee	n/a
Profits Per Employee	-$1.45M
Employee Count	25
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Belite Bio has paid $6,000 in taxes.

Income Tax	6,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +55.62% in the last 52 weeks. The beta is -1.52, so Belite Bio's price volatility has been lower than the market average.

Beta (5Y)	-1.52
52-Week Price Change	+55.62%
50-Day Moving Average	61.09
200-Day Moving Average	58.54
Relative Strength Index (RSI)	46.05
Average Volume (20 Days)	37,737

Short Selling Information

Short Interest	69,987
Short Previous Month	89,202
Short % of Shares Out	0.48%
Short % of Float	n/a
Short Ratio (days to cover)	1.33

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-40.00M
Pretax Income	-31.62M
Net Income	-36.14M
EBITDA	-39.83M
EBIT	-40.00M
Earnings Per Share (EPS)	-$1.18

Full Income Statement

Balance Sheet

The company has $145.15 million in cash and $537,000 in debt, giving a net cash position of $144.61 million or $4.54 per share.

Cash & Cash Equivalents	145.15M
Total Debt	537,000
Net Cash	144.61M
Net Cash Per Share	$4.54
Equity (Book Value)	145.82M
Book Value Per Share	4.58
Working Capital	141.02M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$29.23 million and capital expenditures -$116,000, giving a free cash flow of -$29.35 million.

Operating Cash Flow	-29.23M
Capital Expenditures	-116,000
Free Cash Flow	-29.35M
FCF Per Share	-$0.92

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Belite Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.83%
Shareholder Yield	-14.83%
Earnings Yield	-1.95%
FCF Yield	-1.58%

Analyst Forecast

The average price target for Belite Bio is $96.67, which is 66.67% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$96.67
Price Target Difference	66.67%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1